What factors determine eligibility for hyperbaric oxygen therapy in a patient with an unstable sacral pressure ulcer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hyperbaric Oxygen Therapy for Unstable Sacral Pressure Ulcers

Hyperbaric oxygen therapy (HBOT) is NOT a standard or recommended treatment for sacral pressure ulcers based on current high-quality guidelines, and you should focus on evidence-based interventions instead.

Key Evidence from Guidelines

The 2015 American College of Physicians clinical practice guideline for pressure ulcer treatment 1 comprehensively reviewed adjunctive therapies and does not mention or recommend hyperbaric oxygen therapy at all. This notable absence from a major guideline is significant—the guideline evaluated electromagnetic therapy, negative-pressure wound therapy, therapeutic ultrasound, laser therapy, electrical stimulation, and light therapy, but HBOT was not included among recommended treatments.

The 2024 Wound Healing Society guidelines update 2 similarly does not establish HBOT as a standard treatment modality for pressure ulcers, despite reviewing all available evidence through 2023.

What the Evidence Actually Shows

The available evidence for HBOT in pressure ulcers is:

  • Extremely limited and low quality - mostly case reports and small series 3
  • Lacks credible clinical trials - as acknowledged even by proponents 4
  • Not specific to pressure ulcers - most HBOT literature focuses on diabetic foot ulcers and ischemic wounds 5, 6, 4

When HBOT Might Be Considered (Off-Label)

If you're considering HBOT despite the lack of guideline support, the only scenario with any supporting evidence is:

Pressure ulcer complicated by osteomyelitis 3 - where HBOT is used as adjunctive therapy alongside standard treatment, not as primary therapy

Critical Caveats:

  • HBOT requires numerous sessions to show any effect 4
  • It is always complementary, never primary therapy 4
  • The evidence comes from a single 2024 case report 3, not controlled trials
  • Sacral ulcers with bone involvement had higher complication rates than other locations 1

What You SHOULD Do Instead

Focus on evidence-based treatments that actually work 1:

  1. Support surfaces: Air-fluidized beds (superior evidence for reducing ulcer size)
  2. Nutritional support: Protein or amino acids supplementation (improves healing rate)
  3. Local wound care: Hydrocolloid dressings (superior to gauze)
  4. Adjunctive therapy with evidence: Electrical stimulation (accelerates healing, though watch for skin irritation in frail elderly)
  5. Surgical repair: Consider for advanced-stage ulcers, though reoperation rates are 12-24% 1

Bottom Line

There is no established indication for HBOT in sacral pressure ulcers. The Undersea and Hyperbaric Medical Society's 13 approved indications 6 do not include pressure ulcers as a primary indication. You would not be a candidate for HBOT based on having an unstable sacral wound alone—this is not evidence-based practice.

References

Research

WHS guidelines for the treatment of pressure ulcers-2023 update.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2024

Research

Hyperbaric oxygen therapy.

The journal of the American College of Certified Wound Specialists, 2010

Related Questions

In an elderly bedridden patient with a Stage 4 pressure ulcer exhibiting full‑thickness tissue loss, exposed muscle, slough and moderate exudate, what is the recommended management sequence (including debridement, systemic antibiotics, and dressing selection), when should a collagen dressing be introduced, which dressings are preferred for slough or infection, and what are the indications for negative‑pressure wound therapy (NPWT) or surgical referral?
What comprehensive assessment should be performed for a 78-year-old female who has been unable to walk for three days, has foul‑smelling urine, loose stools, decreased appetite, and a newly developed pressure ulcer?
How should an infected pressure ulcer in an adult be managed, including antimicrobial therapy, surgical debridement, and pressure off‑loading?
How should debridement of a pressure‑ulcer wound be performed in an elderly patient?
Should I start topical enzymatic debridement with Santyl (collagenase) for a stage 3 pressure ulcer that has worsened from 0.2 cm depth with adherent yellow slough to 0.7 cm depth with necrotic slough despite inadequate off‑loading and prior debridement with medical‑grade honey (Manuka honey) and silicone foam dressing?
Is Actemra (tocilizumab) safe for a rheumatoid arthritis patient with diabetes and fatty liver disease who has failed adalimumab therapy?
Can tolperisone be started at 150 mg three times daily in an adult without significant hepatic or renal impairment?
Can hypertension cause aortic stenosis with aortic regurgitation, mild tricuspid regurgitation, mild pulmonary hypertension, and trivial mitral regurgitation?
Will a dobutamine stress echocardiogram provide the same information as a routine transthoracic echocardiogram?
Can diclofenac ophthalmic drops be used to treat a chalazion, and what is the recommended dosing regimen?
What is another name for ipratropium bromide inhalation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.